What does the CRSP options chain show right now?

As of May 15, 2026, CRISPR Therapeutics AG (CRSP) has 71.0K contracts outstanding and 3.4K traded today, with ATM IV of 53.9%. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.

What expirations are available for CRSP options?

The nearest expiration is 28 days out, followed by 34 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.

How tight are CRSP options bid/ask spreads?

Average bid/ask spread across the chain is 24.38%. Wider spreads warrant conservative sizing; mid-market fills are unreliable for retail-size orders.

CRISPR Therapeutics AG (CRSP) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

CRISPR Therapeutics AG (CRSP) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $5.09B, listed on NASDAQ, employing roughly 393 people, carrying a beta of 1.74 to the broader market. CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Led by Samarth Kulkarni, public since 2016-10-19.

Snapshot as of May 15, 2026.

Spot Price: $48.77
Total OI: 71.0K
Total Volume: 3.4K
Front Expiration: 28 days
Second Expiration: 34 days
ATM IV: 53.9%
Avg Bid/Ask Spread: 24.38%

As of May 15, 2026, CRISPR Therapeutics AG (CRSP) has 71.0K open contracts and 3.4K contracts traded. The nearest expiration is 28 days out, followed by 34 days. ATM implied volatility is 53.9%. Average bid/ask spread across the chain is 24.38%: wider spreads, size positions conservatively. The options chain aggregates every listed strike and expiration, letting traders evaluate skew, term structure, and liquidity in a single view.

How CRSP options chain Data Feeds Strategy Selection

Strategy selection on CRISPR Therapeutics AG options does not derive from any single metric in isolation. The options chain view above sits inside a broader read: ATM IV currently sits at 53.9% and dealer gamma exposure is negative, so dealer hedging amplifies directional moves. Combine the options chain data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

Learn how the options chain is reported and how to read the data →

Frequently asked CRSP options chain questions

What does the CRSP options chain show right now?: As of May 15, 2026, CRISPR Therapeutics AG (CRSP) has 71.0K contracts outstanding and 3.4K traded today, with ATM IV of 53.9%. The full chain spans every listed strike and expiration with bid/ask, Greeks, volume, and open interest per contract.
What expirations are available for CRSP options?: The nearest expiration is 28 days out, followed by 34 days. Listed expirations typically extend monthly with weeklies between, plus LEAPS one to two years out for liquid names.
How tight are CRSP options bid/ask spreads?: Average bid/ask spread across the chain is 24.38%. Wider spreads warrant conservative sizing; mid-market fills are unreliable for retail-size orders.